P27

P27 as a Prognostic Factor of Early Cervical Carcinoma
Jiri Bouda, Ondrej Hes, Miroslava Koprivova, Martin Pesek, Tomas Svoboda, Ludmila Boudova

International Journal of Gynecologic Cancer Jan 2013, 23 (1) 164-169; DOI: 10.1097/IGC.0b013e318277edc8
Prognostic Impact of p53, p27, and C-MYC on Clinicopathological Features and Outcome in Early-Stage (FIGO I-II) Epithelial Ovarian Cancer
Ingirídur Anna Skírnisdóttir, Bengt Sorbe, Katarina Lindborg, Tomas Seidal

International Journal of Gynecologic Cancer Jan 2011, 21 (2) 236-244; DOI: 10.1097/IGC.0b013e31820986e5
Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium
S. Erkanli, F. Kayaselcuk, E. Kuscu, T. Bagis, F. Bolat, A. Haberal, B. Demirhan

International Journal of Gynecologic Cancer Apr 2006, 16 (3) 1412-1418; DOI: 10.1136/ijgc-00009577-200605000-00071
Significance of p27 as a predicting marker for medroxyprogesterone acetate therapy against endometrial endometrioid adenocarcinoma
J. Watanabe, K. Watanabe, T. Jobo, Y. Kamata, M. Kawaguchi, M. Imai, I. Okayasu, H. Kuramoto

International Journal of Gynecologic Cancer Jan 2006, 16 (Suppl 1) 452-457; DOI: 10.1136/ijgc-00009577-200602001-00086

Main menu